BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Diagnosis
22 results:

  • 1. Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.
    Ricci C; Ambrosi F; Franceschini T; Giunchi F; Grillini A; Franchini E; Grillini M; Schiavina R; Massari F; Mollica V; Tateo V; Bianchi FM; Bianchi L; Droghetti M; Maloberti T; Tallini G; Colecchia M; Acosta AM; Lobo J; Trpkov K; Fiorentino M; de Biase D
    Virchows Arch; 2023 Nov; 483(5):687-698. PubMed ID: 37845471
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline pten Variants.
    Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
    JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An Overview of Epigenetics in Clear Cell Renal Cell Carcinoma.
    Grammatikaki S; Katifelis H; Farooqi AA; Stravodimos K; Karamouzis MV; Souliotis K; Varvaras D; Gazouli M
    In Vivo; 2023; 37(1):1-10. PubMed ID: 36593023
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
    Sahu DK; Singh N; Das M; Rawat J; Gupta DK
    Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
    Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
    JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of Immunohistochemistry in the Differential diagnosis of Pediatric Renal tumors: Expression of Cyclin D1, Beta-Catenin , PDGFR-Alpha, and pten.
    Kepil N; Batur Ş; Kain ZE; Özcan G; Emre Ş; Özcan R; Celkan TT; Çomunoğlu N
    Turk Patoloji Derg; 2022; 38(2):83-89. PubMed ID: 35147974
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive analysis of pten-related ceRNA network revealing the key pathways WDFY3-AS2 - miR-21-5p/miR-221-3p/miR-222-3p - TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma.
    Zhou X; Liu G; Xu M; Ying X; Li B; Cao F; Cheng S; Xiao B; Cheng M; Liang L; Jia M; Li W; Liu J; Li Z
    Mol Carcinog; 2022 May; 61(5):508-523. PubMed ID: 35129856
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis.
    Chen CV; Croom NA; Simko JP; Stohr BA; Chan E
    Hum Pathol; 2022 Jan; 119():85-93. PubMed ID: 34800526
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.
    Liu D; Augello MA; Grbesa I; Prandi D; Liu Y; Shoag JE; Karnes RJ; Trock BJ; Klein EA; Den RB; Demichelis F; Davicioni E; Sboner A; Barbieri CE
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998599
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Somatic Copy Number Alterations and Associated Genes in Clear-Cell Renal-Cell Carcinoma in Brazilian Patients.
    Fernandes FG; Silveira HCS; Júnior JNA; da Silveira RA; Zucca LE; Cárcano FM; Sanches AON; Neder L; Scapulatempo-Neto C; Serrano SV; Jonasch E; Reis RM; Evangelista AF
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668731
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.
    Zhou J; Singh P; Yin K; Wang J; Bao Y; Wu M; Pathak K; McKinley SK; Braun D; Lubitz CC; Hughes KS
    Ann Surg Oncol; 2021 Oct; 28(11):6590-6600. PubMed ID: 33660127
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Chromophobe renal cell carcinoma: current and controversial issues.
    Moch H; Ohashi R
    Pathology; 2021 Jan; 53(1):101-108. PubMed ID: 33183792
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease.
    Morton SU; Shimamura A; Newburger PE; Opotowsky AR; Quiat D; Pereira AC; Jin SC; Gurvitz M; Brueckner M; Chung WK; Shen Y; Bernstein D; Gelb BD; Giardini A; Goldmuntz E; Kim RW; Lifton RP; Porter GA; Srivastava D; Tristani-Firouzi M; Newburger JW; Seidman JG; Seidman CE
    JAMA Cardiol; 2021 Apr; 6(4):457-462. PubMed ID: 33084842
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Design of a Targeted Sequencing Assay to Detect Rare Mutations in Circulating Tumor DNA.
    Chen J; Chen J; He F; Huang Y; Lu S; Fan H; Wang M; Xu R
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):264-269. PubMed ID: 30986100
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A family with pten mutations with malignancy and an unusually high number of offspring with autism spectrum disorder: a case report.
    Gruhl SL; Sharma P; Han TS
    J Med Case Rep; 2018 Nov; 12(1):353. PubMed ID: 30482242
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Up-regulation of miR-190b promoted growth, invasion, migration and inhibited apoptosis of Wilms' tumor cells by repressing the pten expression.
    An NN; Shawn J; Peng JP; Wu MD; Huang LG
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):961-969. PubMed ID: 29509256
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
    Tusong H; Maolakuerban N; Guan J; Rexiati M; Wang WG; Azhati B; Nuerrula Y; Wang YJ
    Cancer Biomark; 2017; 18(1):79-85. PubMed ID: 27814278
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of pten expression.
    Lipkin JS; Rizvi SM; Gatalica Z; Sarwani NE; Holder SL; Kaag M; Drabick JJ; Joshi M
    Cancer Biol Ther; 2015; 16(1):28-33. PubMed ID: 25692619
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Gene expression correlation for cancer diagnosis: a pilot study.
    Ling B; Chen L; Liu Q; Yang J
    Biomed Res Int; 2014; 2014():253804. PubMed ID: 24818135
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Analysis of pten gene by fluorescent in situ hybridization in renal cell carcinoma.
    de Campos EC; da Fonseca FP; Zequ Sde C; Guimarães GC; Soares FA; Lopes A
    Rev Col Bras Cir; 2013; 40(6):471-5. PubMed ID: 24573625
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.